FDA+ roundup: FDA chief scientist departs to be deputy surgeon general; New transparency on oncology accelerated approvals
Another senior leader at the FDA has moved on, and this time it’s FDA’s chief scientist Denise Hinton, a nearly 20-year agency veteran who has now moved over to serve as deputy surgeon general.
Rear Admiral Hinton, who first joined FDA in 2002, served as FDA’s chief scientist from July 2017 through October, and previously served as deputy director of the FDA’s Office of Medical Policy in the Center for Drug Evaluation and Research, where she concurrently served as Acting OMP Director from 2014 to 2016.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.